Therefore, the purpose of this study was to examine the efficacy of pharmacological inhibition of Drp1 in improving skeletal muscle mitochondrial dynamics and function, insulin sensitivity, and whole‐body glucose metabolism in an obesity‐induced insulin‐resistant condition. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.